Morinidazole |
Katalog-Nr.GC32157 |
Morinidazol ist ein oral aktiver antimikrobieller 5-Nitroimidazol-Wirkstoff, der beim Menschen Über N+--Glucuronidierung und Sulfatierung umfassend verstoffwechselt wird.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 92478-27-8
Sample solution is provided at 25 µL, 10mM.
Morinidazole is a novel 5-nitroimidazole antimicrobial drug that undergoes extensive metabolism in humans via N+-glucuronidation and sulfation, for the treatment of bacterial infections including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria.
[1]. Zhong K, et al. Effects of renal impairment on the pharmacokinetics of morinidazole: uptake transporter-mediated renal clearanceof the conjugated metabolites. Antimicrob Agents Chemother. 2014 Jul;58(7):4153-61.
Average Rating: 5
(Based on Reviews and 36 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *